Non Insulin Based Type 2 Diabetes Therapy
- Technology Benefits
- The inventors have developed novel molecules that have been demonstrated to be safe and effective in an animal model of diabetes (rodent) Can be taken orally unlike insulin, eliminating the need for painful injections As an a therapy which restores the body's ability to regulate blood glucose on its own, it will lead to better real time glucose management, alleviating the deleterious health effects of hyperglycemia A metabolic precursor to this molecule has been used for 5 decades to treat unrelated conditions and has proven itself to be safe and well tolerated by patients Most current therapies have adverse side effects, including hypoglycemia (low blood sugar) and weight gain, this may eliminate those
- Technology Application
- A new, non-insulin based therapy for type 2 diabetes to aid the body's native insulin response to blood glucose levels, may be used independently or in conjunction with other therapies Use of a radiolabeled variant of the inhibitor to target beta cells in the pancreas and quantify progression of disease based on degree of labeling
- Detailed Technology Description
- One of the factors contributing to type 2 diabetes is impaired beta cell function and loss of response to hyperglycemic stimulus. The invention is a novel inhibitor of an ATP dependent transporter molecule expressed in beta cells, which is responsibl...
- *Abstract
-
None
- *Inquiry
- Peter GolikovColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- 2024
- *Principal Investigator
-
- *Publications
- Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas, J Mol Histol. 2008 Oct;39(5):543-51
- *Web Links
- WIPO: WO/2008/112278
- Country/Region
- USA
For more information, please click Here
